Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Recommends Security Patch For St. Jude Wireless Cardiac Devices

Executive Summary

Following months of bickering between St. Jude and Muddy Waters Research, US FDA issued a safety alert for the device-maker's wireless cardiac devices. The agency says there's a risk for malicious cyber-attacks and recommends a software patch to minimize risk.

Advertisement

Related Content

Despite US FDA Alert, Abbott-Muddy Waters Lawsuit Continues
US FDA Warning Letter Scrutinizes Abbott Over Cybersecurity, Battery Lapses
Get 'HIP'AA To Digital Medtech Law: More Than Just FDA To Worry About
Medtech Cybersecurity Whistleblowers: Traditional Protections, Incentives Apply
Abbott Finally Joins MRI-Compatibility Club In US CRM Market
Abbott's Robert Ford: Device Chief Looks Ahead After St. Jude Deal
Lawmakers Question FDA On Medical Device Cybersecurity Concerns
St. Jude Hacking-Risk Allegations: US FDA Continues Assessment, As Firm Files Lawsuit
St. Jude, Short-Seller Wrestle Over Alleged Security Vulnerabilities

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT104290

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel